Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,600 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06782646Enrolling by invitationPhase 2/Phase 3
Can berberine help lower cholesterol in Chinese women?
This trial tests whether berberine, a natural supplement, can lower cholesterol and fats in the blood specifically in Chinese women. It aims to see if berberine works differently for women than for men.
Hong KongAges 20–65 - NCT06782087Enrolling by invitationPhase 1
Laser vs. nano-chitosan gel for whitening dead teeth
This study tests two methods to whiten teeth that have had root canal treatment. It compares using a diode laser with a special gel to see which works better for lightening discolored front teeth.
Giza, EgyptAges 18–40 - NCT06777693Enrolling by invitation
Unified Protocol for emotional disorders in older adults
This study tests a group therapy program for older adults with anxiety or depression. The program teaches skills to manage difficult emotions and improve emotional well-being.
Bergen, VestlandAges 65 years+ - NCT06777173Enrolling by invitation
Antiviral and Immunotherapy for Chronic Hepatitis B
This study tests a new combination of antiviral medicine and an immune-boosting therapy for adults with chronic hepatitis B. It is designed for people who are in the active phase of the infection and have not been treated before.
BeijingAges 18–65 - NCT06763783Enrolling by invitationPhase 4
Shingles vaccine study for people with rheumatic diseases
This study offers the Shingrix shingles vaccine for free to adults with inflammatory rheumatic diseases. It compares how well the vaccine works in people taking immune-suppressing drugs versus those not taking them.
LundAges 18 years+ - NCT06761521Enrolling by invitation
Monitoring implant health with aMMP-8 test
This study uses a special test to check for inflammation around dental implants. It may help catch problems early and is for people who already have implants.
Helsinki, UusimaaAges Any age - NCT06758778Enrolling by invitation
How the body processes fish oil and other supplements
This study compares how healthy adults absorb fish oil (CreNeuroS CNS Fish Oil Plus) with two approved medicines (Vascepa and Deplin). It helps researchers understand if the new product works similarly in the body.
Hyderabad, TelanganaAges 18–45 - NCT06755944Enrolling by invitationPhase 2/Phase 3
Study of XY03-EA tablets for recent stroke recovery
This trial tests whether XY03-EA tablets can help people recover after an acute ischemic stroke. Participants must have had a stroke within the last 48 hours and have moderate to severe symptoms but not be in a coma.
Shijiazhuang, HebeiAges 18–80 - NCT06755515Enrolling by invitationPhase 2/Phase 3
Rulonilimab + Chemo for Advanced Cervical Cancer
This trial tests a new drug called Rulonilimab combined with chemotherapy, with or without bevacizumab, as the first treatment for cervical cancer that has spread or come back. It’s for people whose tumors have a specific marker (PD-L1) and who haven’t had other treatments for advanced disease.
Linyi, ShandongAges 18 years+ - NCT06753227Enrolling by invitation
Comparing ways to measure valve pressure after TAVI
This trial looks at how well a new method (using echo) compares to the standard invasive method for measuring pressure across the new valve after TAVI. It may help doctors monitor your valve function with less risk.
Munich, BavariaAges 18 years+ - NCT06749808Enrolling by invitation
Nutritional supplement study for wellness and nutrient absorption
This trial tests whether a nutritional supplement can improve wellbeing and help your body absorb nutrients better. It might be a good fit if you are generally healthy and not already taking high-dose carotenoid supplements.
Provo, UtahAges 20–65 - NCT06748014Enrolling by invitationEarly Phase 1
Study of aescin plus MPFF for bleeding hemorrhoids
This study tests whether a combination of two medicines (aescin and MPFF) can stop bleeding from mild internal hemorrhoids (grade 1 or 2) and prevent it from coming back. If you have had active bleeding within the past 7 days, this trial may help you find an effective non-surgical treatment.
Chiang Mai, MaungAges 20 years+ - NCT06747546Enrolling by invitation
Oxygen-based blood flow management after heart surgery
This study is testing a new way to manage blood flow after heart surgery in children with congenital heart disease. The goal is to make sure the body gets the right amount of oxygen to help recovery.
Minhang, Shanghai MunicipalityAges 1 week–18 years - NCT06737354Enrolling by invitationPhase 1
Study of IVB103 injection for wet age-related macular degeneration
This trial tests a new treatment called IVB103 for people with wet age-related macular degeneration (AMD). It aims to see if the injection is safe and effective for those who have already had anti-VEGF therapy. You may qualify if you have active disease and have had at least two prior anti-VEGF treatments.
Chengdu, SichuanAges 50 years+ - NCT06735573Enrolling by invitation
Protein, muscle loss, obesity, and COPD study
This study tests whether a protein intervention can help women over 55 with COPD who also have muscle loss and obesity. It aims to improve their strength and health.
Aberdeen, ScotlandAges 55 years+ - NCT06723015Enrolling by invitationPhase 2
Tau PET in anti-amyloid therapy for Alzheimer's
This study uses brain scans to see how anti-amyloid treatments affect tau protein buildup in people with early Alzheimer's. If you have mild cognitive impairment or mild Alzheimer's, you may be eligible to help understand how these treatments work.
Rochester, MinnesotaAges 50–90 - NCT06718036Enrolling by invitation
Rehabilitation study for chronic conditions
This trial tests a new way to measure how well rehabilitation is working for people with long-term health problems like nerve, heart, lung, or muscle and bone conditions. It will help doctors better understand your recovery.
RzeszówAges 18–65 - NCT06714084Enrolling by invitation
Treating high-risk cervical cancer with chemoradiation and immunotherapy
This trial tests a new drug called Cardenimumab combined with standard chemotherapy and radiation for women with high-risk cervical cancer. The goal is to see if adding this drug can improve outcomes for patients whose tumors are large, have spread to lymph nodes, or are stage IV.
Wuhan, HubeiAges 18–75 - NCT06708000Enrolling by invitationPhase 3
Personalized testing for new chest pain
This trial compares a personalized evaluation approach to standard care for people with new chest pain who might have heart disease. It aims to see if tailoring tests can improve diagnosis and outcomes.
HerningAges 30–75 - NCT06707922Enrolling by invitation
Long-term follow-up for hepatitis B treatment
This study follows patients who completed a previous trial of peginterferon alfa-2b and tenofovir for chronic hepatitis B. It checks long-term health and offers further treatment options based on your response to the earlier therapy.
BeijingAges 18 years+ - NCT06705049Enrolling by invitation
Study on cancer spread to the lining of the brain
This study looks at how solid tumors spread to the lining of the brain and spinal cord. It aims to understand this condition better by reviewing patient records.
ShanghaiAges 18–80 - NCT06703801Enrolling by invitation
Tracking pulmonary hypertension and quality of life
This study is tracking people with pulmonary hypertension (high blood pressure in the lungs) over time to see how their condition and quality of life change. By joining, you help doctors better understand the disease and improve care for others like you.
Hong KongAges 19 years+ - NCT06699953Enrolling by invitation
EEG study of fentanyl and how it relates to drug liking
This study looks at how fentanyl affects brain waves (EEG) and whether those brain changes are linked to how much a person likes the drug. If you are having surgery with fentanyl, you may be able to join.
Palo Alto, CaliforniaAges 18 years+ - NCT06696456Enrolling by invitation
Long-term follow-up of gene therapy for otoferlin hearing loss
This study follows up with people who received a gene therapy (AAVAnc80-hOTOF) in a previous clinical trial. It checks how well the treatment works over time and how safe it is.
Iowa City, IowaAges Any age
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,600 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.